GTS-21 (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "GTS-21" in Russian language version.

refsWebsite

Global rank Russian rank

14nih.gov

4^th place

6^th place

10wikipedia.org

low place

5doi.org

2^nd place

3^rd place

2archive.org

6^th place

9^th place

archive.org

Freedman R., Olincy A., Buchanan R. W., Harris J. G., Gold J. M., Johnson L. et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. (англ.) // American Journal of Psychiatry : journal. — 2008. — Vol. 165, no. 8. — P. 1040—1047. — doi:10.1176/appi.ajp.2008.07071135. — PMID 18381905. — PMC 3746983.
De Fiebre N. C., De Fiebre C. M. Alpha 7 nicotinic acetylcholine receptor-mediated protection against ethanol-induced neurotoxicity. (англ.) // Alcohol : journal. — 2003. — Vol. 31, no. 3. — P. 149—153. — PMID 14693263.

doi.org

dx.doi.org

Martin L. F., Kem W. R., Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. (англ.) // Psychopharmacology^[англ.] : journal. — Springer, 2004. — Vol. 174. — P. 54—64. — doi:10.1007/s00213-003-1750-1. — PMID 15205879.
Olincy A., Stevens K. E. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. (англ.) // Biochemical pharmacology : journal. — 2007. — Vol. 74, no. 8. — P. 1192—1201. — doi:10.1016/j.bcp.2007.07.015. — PMID 17714692. — PMC 2134979.
Olincy A., Harris J.G., Johnson L.L., Pender V., Kongs S., Allensworth D et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. (англ.) // Archives of general psychiatry^[англ.] : journal. — 2006. — Vol. 63, no. 6. — P. 630—638. — doi:10.1001/archpsyc.63.6.630. — PMID 16754836.
Freedman R., Olincy A., Buchanan R. W., Harris J. G., Gold J. M., Johnson L. et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. (англ.) // American Journal of Psychiatry : journal. — 2008. — Vol. 165, no. 8. — P. 1040—1047. — doi:10.1176/appi.ajp.2008.07071135. — PMID 18381905. — PMC 3746983.
Kitagawa H., Takenouchi T., Azuma R., Wesnes K. A., Kramer W. G., Clody D. E. et al. Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. (англ.) // Neuropsychopharmacology^[англ.] : journal. — Nature Publishing Group, 2003. — Vol. 28, no. 3. — P. 542—551. — doi:10.1038/sj.npp.1300028. — PMID 12629535.

nih.gov

ncbi.nlm.nih.gov

Simosky J. K., Stevens K.E., Freedman R. Nicotinic agonists and psychosis. (неопр.) // Current drug targets. CNS and neurological disorders. — 2002. — Т. 1, № 2. — С. 149—162. — PMID 12769624.
Martin L. F., Kem W. R., Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. (англ.) // Psychopharmacology^[англ.] : journal. — Springer, 2004. — Vol. 174. — P. 54—64. — doi:10.1007/s00213-003-1750-1. — PMID 15205879.
Olincy A., Stevens K. E. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. (англ.) // Biochemical pharmacology : journal. — 2007. — Vol. 74, no. 8. — P. 1192—1201. — doi:10.1016/j.bcp.2007.07.015. — PMID 17714692. — PMC 2134979.
Olincy A., Harris J.G., Johnson L.L., Pender V., Kongs S., Allensworth D et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. (англ.) // Archives of general psychiatry^[англ.] : journal. — 2006. — Vol. 63, no. 6. — P. 630—638. — doi:10.1001/archpsyc.63.6.630. — PMID 16754836.
Freedman R., Olincy A., Buchanan R. W., Harris J. G., Gold J. M., Johnson L. et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. (англ.) // American Journal of Psychiatry : journal. — 2008. — Vol. 165, no. 8. — P. 1040—1047. — doi:10.1176/appi.ajp.2008.07071135. — PMID 18381905. — PMC 3746983.
Kitagawa H., Takenouchi T., Azuma R., Wesnes K. A., Kramer W. G., Clody D. E. et al. Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. (англ.) // Neuropsychopharmacology^[англ.] : journal. — Nature Publishing Group, 2003. — Vol. 28, no. 3. — P. 542—551. — doi:10.1038/sj.npp.1300028. — PMID 12629535.
Meyer E. M., King M. A., Meyers C. Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. (англ.) // Brain Research^[англ.] : journal. — 1998. — Vol. 786, no. 1—2. — P. 252—254. — PMID 9555043.
Shimohama S., Greenwald D. L., Shafron D. H., Akaika A., Maeda T., Kaneko S. et al. Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. (англ.) // Brain Research^[англ.] : journal. — 1998. — Vol. 779, no. 1—2. — P. 359—63. — PMID 9473725.
Li Y., Meyer E. M., Walker D. W., Millard W. J., He Y. J., King M. A. Alpha7 nicotinic receptor activation inhibits ethanol-induced mitochondrial dysfunction, cytochrome c release and neurotoxicity in primary rat hippocampal neuronal cultures. (англ.) // Journal of neurochemistry^[англ.] : journal. — 2002. — Vol. 81, no. 4. — P. 853—858. — PMID 12065644.
De Fiebre N. C., De Fiebre C. M. Alpha 7 nicotinic acetylcholine receptor-mediated protection against ethanol-induced neurotoxicity. (англ.) // Alcohol : journal. — 2003. — Vol. 31, no. 3. — P. 149—153. — PMID 14693263.
Kem W. R. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). (англ.) // Behavioural brain research^[англ.] : journal. — 2000. — Vol. 113, no. 1—2. — P. 169—181. — PMID 10942043.
Briggs C. A., Anderson D. J., Brioni J. D., Buccafusco J. J., Buckley M. J., Campbell J. E. et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. (англ.) // Pharmacol Biochem Behav^[англ.] : journal. — 1997. — Vol. 57, no. 1—2. — P. 231—241. — PMID 9164577.
Meyer E. M., Tay E. T., Papke R. L., Meyers C., Huang G. L., De Fiebre C.M. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. (англ.) // Brain Research^[англ.] : journal. — 1997. — Vol. 768, no. 1—2. — P. 49—56. — PMID 9369300.
William Kem, Ferenc Soti, Kristin Wildeboer, Susan LeFrancois, Kelly MacDougall, Dong-Qing Wei, Kuo-Chen Chou, Hugo R. Arias. The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties (англ.) // Marine Drugs^[англ.] : journal. — 2006. — Vol. 4, no. 3. — P. 255—273. — PMC 3663414.

wikipedia.org

en.wikipedia.org

Martin L. F., Kem W. R., Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. (англ.) // Psychopharmacology^[англ.] : journal. — Springer, 2004. — Vol. 174. — P. 54—64. — doi:10.1007/s00213-003-1750-1. — PMID 15205879.
Olincy A., Harris J.G., Johnson L.L., Pender V., Kongs S., Allensworth D et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. (англ.) // Archives of general psychiatry^[англ.] : journal. — 2006. — Vol. 63, no. 6. — P. 630—638. — doi:10.1001/archpsyc.63.6.630. — PMID 16754836.
Kitagawa H., Takenouchi T., Azuma R., Wesnes K. A., Kramer W. G., Clody D. E. et al. Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. (англ.) // Neuropsychopharmacology^[англ.] : journal. — Nature Publishing Group, 2003. — Vol. 28, no. 3. — P. 542—551. — doi:10.1038/sj.npp.1300028. — PMID 12629535.
Meyer E. M., King M. A., Meyers C. Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. (англ.) // Brain Research^[англ.] : journal. — 1998. — Vol. 786, no. 1—2. — P. 252—254. — PMID 9555043.
Shimohama S., Greenwald D. L., Shafron D. H., Akaika A., Maeda T., Kaneko S. et al. Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. (англ.) // Brain Research^[англ.] : journal. — 1998. — Vol. 779, no. 1—2. — P. 359—63. — PMID 9473725.
Li Y., Meyer E. M., Walker D. W., Millard W. J., He Y. J., King M. A. Alpha7 nicotinic receptor activation inhibits ethanol-induced mitochondrial dysfunction, cytochrome c release and neurotoxicity in primary rat hippocampal neuronal cultures. (англ.) // Journal of neurochemistry^[англ.] : journal. — 2002. — Vol. 81, no. 4. — P. 853—858. — PMID 12065644.
Kem W. R. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). (англ.) // Behavioural brain research^[англ.] : journal. — 2000. — Vol. 113, no. 1—2. — P. 169—181. — PMID 10942043.
Briggs C. A., Anderson D. J., Brioni J. D., Buccafusco J. J., Buckley M. J., Campbell J. E. et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. (англ.) // Pharmacol Biochem Behav^[англ.] : journal. — 1997. — Vol. 57, no. 1—2. — P. 231—241. — PMID 9164577.
Meyer E. M., Tay E. T., Papke R. L., Meyers C., Huang G. L., De Fiebre C.M. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. (англ.) // Brain Research^[англ.] : journal. — 1997. — Vol. 768, no. 1—2. — P. 49—56. — PMID 9369300.
William Kem, Ferenc Soti, Kristin Wildeboer, Susan LeFrancois, Kelly MacDougall, Dong-Qing Wei, Kuo-Chen Chou, Hugo R. Arias. The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties (англ.) // Marine Drugs^[англ.] : journal. — 2006. — Vol. 4, no. 3. — P. 255—273. — PMC 3663414.